KLRK1 and acute myeloid leukemia: Furthermore, AML cells can preferentially evade immune surveillance by downregulating the expression of major histocompatibility complexes (MHC) and natural killer group 2 member D (NKG2D) ligands, which are required for immune recognition by T- and NK-cells, respectively [59,60,61].